Detroit and its outgoing mayor offer a playbook for big-city comebacks

Zohran Mamdani could learn a lot from Mike Duggan.

NRG Therapeutics Announces Senior Appointments as it Advances NRG5051 Towards First-in-Human Clinical Studies

NRG Therapeutics Ltd. (“NRG”), an innovative neuroscience company targeting a novel mechanism to address mitochondrial ...
News-Medical.Net on MSN

Epidural stimulation and physical rehabilitation can enhance recovery in spinal cord injury patients

Spinal cord injury (SCI) causes paralysis in roughly one million people worldwide, with incident cases rising yearly.
ScienceAlert on MSN

Parkinson's Discovery Suggests We May Have an FDA-Approved Treatment Already

Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...

Hull-area couple on the rare illness that has struck their young son

Ezra has mitochondrial disease - a complex, life-limiting condition - which his parents want to raise awareness of ...
Medical Dialogues

Patients with MetALD undergo significantly higher risks of severe liver complications compared to those with MASLD: Study

A new study published in The Lancet Gastroenterology and Hepatology revealed that individuals with metabolic dysfunction and ...

'My baby didn't cry getting his vaccinations... we knew something wasn't right'

Laura continued: "Near Ezra's first birthday we took him in for his vaccinations. He didn't cry or even flinch at these. The ...
BMJ Open

Aerobic dance during chemotherapy in patients with breast cancer with cognitive impairment (ADANC): protocol for an assessor-blinded randomised clinical trial

Introduction Therapeutic exercise has been used to improve cancer-related dysfunction. Recent studies suggest that exercise ...

Johnson & Johnson: TECVAYLI plus DARZALEX FASPRO combination regimen significantly improves progression-free survival and overall survival versus standard of care

First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line ...